Jennison Associates
CHRS icon

Jennison Associates’s Coherus Oncology CHRS Stock Holding History

Jennison Associates’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-26,840
Closed -$443K – 652
2018
Q3 		$443K Sell
26,840
-334
-1% -$5.92K ﹤0.01% 639
2018
Q2 		$380K Sell
27,174
-968
-3% -$13.9K ﹤0.01% 638
2018
Q1 		$311K Buy
+28,142
New +$308K ﹤0.01% 630
2017
Q3 		– Sell
-18,200
Closed -$261K – 659
2017
Q2 		$261K Buy
18,200
+69
+0.4% +$1.33K ﹤0.01% 631
2017
Q1 		$383K Sell
18,131
-764
-4% -$18.8K ﹤0.01% 621
2016
Q4 		$532K Buy
18,895
+4,470
+31% +$125K ﹤0.01% 671
2016
Q3 		$386K Buy
14,425
+932
+7% +$25.4K ﹤0.01% 620
2016
Q2 		$228K Buy
+13,493
New +$253K ﹤0.01% 629
2016
Q1 		– Sell
-367,021
Closed -$8.43M – 620
2015
Q4 		$8.43M Buy
367,021
+11,023
+3% +$284K 0.01% 487
2015
Q3 		$7.13M Buy
355,998
+2,635
+0.7% +$80.2K 0.01% 524
2015
Q2 		$10.2M Buy
+353,363
New +$8.93M 0.01% 514

Other funds holding CHRS

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $29.7B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2B AUM 117.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return